A61K 35/766
Rhabdovirus
Official title: Rhabdovirus, e.g. vesicular stomatitis virus
A61K35/766 (Rhabdovirus) appears on 72 US grants and 161 published applications in this corpus.
Search patents in A61K- Granted patents
- 72
- Published applications
- 161
- Assignees
- 79
- Inventors
- 240
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 4 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 0 | 4 |
| 2012 | 1 | 5 |
| 2013 | 1 | 3 |
| 2014 | 1 | 8 |
| 2015 | 2 | 5 |
| 2016 | 5 | 6 |
| 2017 | 3 | 7 |
| 2018 | 5 | 6 |
| 2019 | 6 | 16 |
| 2020 | 10 | 9 |
| 2021 | 4 | 16 |
| 2022 | 2 | 12 |
| 2023 | 9 | 11 |
| 2024 | 6 | 20 |
| 2025 | 9 | 13 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oncolytic virus in combination with immune checkpoint inhibitor for treating tumors15 Sep 2026US 12,734,202 B2Joint Biosciences (Sh) Ltd.
- Sequential heterologous boost oncolytic viral immunotherapy25 Aug 2026US 12,714,733 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Methods and materials for treating cancer4 Aug 2026US 12,697,361 B2Mayo Foundation for Medical Education and Research
- Compositions and methods of use of oncolytic virus like vesicles17 Mar 2026US 12,577,585 B2Carogen Corporation
- VSV chimeric vectors13 Jan 2026US 12,522,844 B2Boehringer Ingelheim International GmbH
- Composition including virus like particles (vlps), a kit, and method for antitumoral therapy13 Aug 2026US 2026/0234573 A1Cnpem- Centro Nacional De Pesquisa Em Energia E Materiais
- Stabilization of virus-based therapeutic agent14 May 2026US 2026/0130983 A1Elarex Inc.
- Macrophage depletion and vesicular stomatitis virus for treatment of cancer7 May 2026US 2026/0125459 A1Boehringer Ingelheim International GmbH
- Recombinant rhabdovirus encoding for a gasdermin30 Apr 2026US 2026/0117200 A1Boehringer Ingelheim International GmbH
- Manufacturing systems and methods for cellular therapeutic platforms22 Jan 2026US 2026/0021053 A1
Most cited
By later US patents
- Method for treatment of osteoporosis18US 6,165,515 ANippon Zoki Pharmaceutical Co., Ltd. · 2000
- Purging of cells using viruses12US 7,192,580 B2University of Ottawa · 2007
- Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof10US 10,232,003 B2BeneVir Biopharm, Inc. · 2019
- Oncolytic virus for expression of immune checkpoint modulators9US 10,555,981 B2Transgene S.A. · 2020
- Treatment of infections in animals7US 4,049,794 ABayer Aktiengesellschaft · 1977